Glucose Targets in gestational diabetes Pilot
An evaluation of the safety of very tight glycaemic control versus tight glycaemic control in women with gestational diabetes
Women's and Children's Hospital
40 participants
Dec 4, 2014
Interventional
Conditions
Summary
A pilot study of maternal and neonatal outcomes of pregnancies complicated by gestational diabetes, including significant maternal hypoglycaemia and lack of neonatal hypoglycaemia: the main hypothesis is that these will not differ when receiving treatment aimed at achieving ‘very tight’ blood glucose targets, compared with treatment aimed at achieving ‘tight’ blood glucose targets
Eligibility
Inclusion Criteria1
- Pregnant women with gestational diabetes diagnosed on 75g OGTT: fasting glucose >=5.5 mmol/L and 2h glucose >=8.5 mmol/L, between 12 and 30 weeks gestation, with a singleton or twin pregnancy, not previously diagnosed as diabetic, attending antenatal care at collaborating hospitals, and giving informed written consent
Exclusion Criteria1
- >30+0 weeks gestation, or with triplets or higher order gravidity, or with major active medical disorders (including psychiatric disease requiring antipsychotic medication and inflammatory disorders requiring corticosteroid therapy, but not including chronic hypertension)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Very tight glycaemic control as monitored by self blood glucose monitoring with a memory glucometer, aiming to keep fasting capillary blood glucose <5.0 mmol/L and 2 hour post prandial capillary blood glucose <6.7 mmol/L until delivery, using diet, exercise, insulin, other drugs, as necessary, and at appropriate doses to maintain the control, under the supervision of an obstetric physician and a diabetes nurse educator
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12614001250628